Results 171 to 180 of about 46,021 (228)

Re-emergence of vaccine-preventable diseases in the post-elimination era. [PDF]

PLoS Med
Kumar CK, Lo NC.
europepmc   +1 more source

Progress and gaps in poliovirus immunity: Evidence from a serological survey of children aged 6-23 months in high-risk districts of Pakistan. [PDF]

NPJ Vaccines
Hussain I, Khan A, Umer M, Sajid M, Abbas H, Alam MM, Haq MA, Bosan A, Hafiz R, Partridge J, Soofi S.   +10 more
europepmc   +1 more source

Ethiopia towards polio eradication: insights from acute flaccid paralysis surveillance data analysis 2016 to 2023. [PDF]

Pan Afr Med J
Mulugeta GT, Alemu MA, Gelaw AZ, Nibzane GT, Guiadie HT, Manyazewal MT, Getaneh MW, Afele MA.   +7 more
europepmc   +1 more source

Commentary on "Exploring the Phenotypic Profile of Acute Flaccid Paralysis: Insights from a Third-Level Pediatric Emergency Room". [PDF]

Iran J Child Neurol
Hosseinpour S, Ashrafi MR, Heidari M, Parvaneh N, Tavasoli AR.   +4 more
europepmc   +1 more source

The Role of Human Viral Entry Receptor Mouse Models in Advancing Antiviral Antibodies and Vaccines. [PDF]

Vaccines (Basel)
Zuo N, Zheng X, Ishaq R, Ren D, Hu A.
europepmc   +1 more source

Uncovering the spatiotemporal patterns of the largest vaccine-derived poliovirus serotype 2 outbreak in the Democratic Republic of the Congo

Candido DdS, Chopra K, Mampuela TK, Shaw A, Jorgensen D, Martin J, Pratt C, Lofiko E, Lemey P, Riziki Y, Grassly N, Mbala P, Blake I.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Inactivated poliovirus vaccine and the final stages of poliovirus eradication

Vaccine, 2001
The use of the inactivated poliovirus vaccine (IPV) will increase before and probably also after the global eradication of the wild type poliovirus. Before eradication, the switch from the use of oral poliovirus vaccine (OPV) to IPV has been due to the better safety record of IPV. Introduction of IPV in the regular immunisation schedules is made easier
exaly   +3 more sources

GENETICS OF POLIOVIRUS

Annual Review of Genetics, 1993
INFECTIOUS eDNA AND IN VITRO SYNTHESIS OF INFECTIOUS VIRAL RNA 359 SELECTION AND GENERATION OF MUTANTS . . . . . . .... . . .. . . .. . . 360 Selection of Spontaneous Mutants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 363 Random Mutagenesis .... _ . . . . . . . _ _ .... ... ... _ _ . . . . . . . . . 370 Mutagenesis Targeted to Existing
E, Wimmer, C U, Hellen, X, Cao
openaire   +2 more sources

Poliovirus and Apoptosis

2004
Poliovirus (PV) is the causal agent of paralytic poliomyelitis, an acute disease of the central nervous system (CNS). A killed and an oral live attenuated vaccine were both developed in the 1950s (Salk 1955; Sabin and Boulger 1973), and subsequent massive vaccination campaigns resulted in near total eradication of PV from most industrialized countries:
Blondel, B., Couderc, Thérèse, Simonin, Yannick, Gosselin, Anne-Sophie, Guivel-Benhassine, F.   +4 more
openaire   +3 more sources